Key facts
- It has raised $25.3M; the latest was Debt - General ($980K) in Jul 2025.
- Notable investors include US National Science Foundation, Alexandria Venture Investments, SVG Ventures|THRIVE, iSelect Fund, AgriTech Capital (North Wilmington) — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Harpe Bio Herbicide
- ·The full record, as it builds
Funding rounds
No funding rounds for Harpe Bio Herbicide are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Harpe Bio Herbicide
Provider of biological herbicides intended to provide superior natural crop protection. The company offers biological herbicides, which are made using a series of novel plant extracts and control a wide spectrum of weeds, including those with resistance to synthetic chemistries, enabling farmers to manage weeds and improve crop production in a safe, sustainable, and eco-friendly manner.
- Sector
- Materials and Resources
- HQ
- Raleigh, NC, United States
- Founded
- 2020
- Employees
- 10
- Website
- harpebio.com/
- Ownership
- Privately Held (backing)
Harpe Bio Herbicide doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Harpe Bio Herbicide shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Harpe Bio Herbicide in its N-PORT filings yet. We sweep new filings monthly.